Bristol-Myers Squibb Financial Health
Profitability:6.01/10
✅ Bristol-Myers Squibb has better Profitability than 63.64% of the companies on the Drug Manufacturers industry
Net Margin: 13.15%
❌ Bristol-Myers Squibb has worst Net Margin than 55.56% of the companies on the Drug Manufacturers industry
ROE (Return on Equity): 3.42%
✅ Bristol-Myers Squibb has better ROE (Return on Equity) than 55.56% of the companies on the Drug Manufacturers industry
ROA (Return on Assets): 1.24%
❌ Bristol-Myers Squibb has worst ROA (Return on Assets) than 57.14% of the companies on the Drug Manufacturers industry
Operating Efficiency:0/10
✅ Bristol-Myers Squibb has better Operating Efficiency than 100% of the companies on the Drug Manufacturers industry
Operating Margin: 0%
✅ Bristol-Myers Squibb has better Operating Margin than 100% of the companies on the Drug Manufacturers industry
Liquidity:6.09/10
✅ Bristol-Myers Squibb has better Liquidity than 75% of the companies on the Drug Manufacturers industry
Quick Ratio: 1.37
✅ Bristol-Myers Squibb has better Quick Ratio than 75% of the companies on the Drug Manufacturers industry
Operating Cash Flow Ratio: 0.44
✅ Bristol-Myers Squibb has better Operating Cash Flow Ratio than 57.14% of the companies on the Drug Manufacturers industry
Solvency:5.36/10
❌ Bristol-Myers Squibb has worst Solvency than 66.67% of the companies on the Drug Manufacturers industry
Debt to Equity Ratio: 0.9
✅ Bristol-Myers Squibb has better Debt to Equity Ratio than 57.14% of the companies on the Drug Manufacturers industry
Interest Coverage Ratio: 0.44
✅ Bristol-Myers Squibb has better Interest Coverage Ratio than 57.14% of the companies on the Drug Manufacturers industry